1.45  0 (0%)		04-29 14:03
Open: 1.45 High: 1.48 Volume: 141,712		Pre. Close: 1.45 Low: 1.375 Market Cap: 54(M)

Short term
Mid term
Targets	6-month :	2.85	1-year :	3.79
Resists	First :	2.44	Second :	3.25
Pivot price	1.42
Supports	First :	1.14	Second :	0.95
MAs	MA(5) :	1.49	MA(20) :	1.39
	MA(100) :	1.86	MA(250) :	2.53
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	13.4	D(3) :	15.2
RSI	RSI(14): 48.8
52-week	High :	4.4	Low :	1.14

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MLEC ] has closed below upper band by 49.8%. Bollinger Bands are 172.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.51 - 1.52	1.52 - 1.53
Low:	1.32 - 1.33	1.33 - 1.33
Close:	1.43 - 1.45	1.45 - 1.46

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Sat, 27 Apr 2024
Moolec Science SA (NASDAQ:MLEC) Short Interest Up 56.9% in April - MarketBeat

Tue, 23 Apr 2024
Top 2 Risk Off Stocks You May Want To Dump In Q2 - Moolec Science (NASDAQ:MLEC), Yatsen Holding (NYSE:YSG - Benzinga

Mon, 22 Apr 2024
MLEC Stock Price and Chart — NASDAQ:MLEC — TradingView - TradingView

Mon, 22 Apr 2024
Why Shares Of Moolec Science Are Skyrocketing Today - Moolec Science (NASDAQ:MLEC) - Benzinga

Mon, 22 Apr 2024
Is Moolec Science (NASDAQ:MLEC) A Risky Investment? - Simply Wall St

Mon, 22 Apr 2024
Moolec achieves USDA approval for plant-grown animal proteins, shares jump (NASDAQ:MLEC) - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	38 (M)
Shares Float	18 (M)
Held by Insiders	80.2 (%)
Held by Institutions	0 (%)
Shares Short	5 (K)
Shares Short P.Month	21 (K)

EPS	-1.4
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.18
Profit Margin	-208.6 %
Operating Margin	-387.3 %
Return on Assets (ttm)	-26.8 %
Return on Equity (ttm)	-69.8 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0.08
EBITDA (p.s.)	-0.25
Qtrly Earnings Growth	0 %
Operating Cash Flow	-13 (M)
Levered Free Cash Flow	-12 (M)

PE Ratio	-1.03
PEG Ratio	0
Price to Book value	7.94
Price to Sales	17.27
Price to Cash Flow	-4.27

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.